An intrinsic characteristic of cancer is its ability to evade the immune response, with tumor cells mediating immune evasion by expressing PD-L1 ligands and interacting with PD-1 on T cells, thereby inhibiting T cell activity. This evidence concerns the gene PDCD1 and neoplasm.